April 7, 2025 10:18 AM EDT

Lexeo discloses new data for heart drug; Spark Therapeutics to lay off workers

ENDPOINTS

Plus, news about Kashiv BioSciences:

Lexeo Therapeutics reveals early data for heart disease drug: The New York biotech said LX2006

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Trump asks 'very tough hombre' Dr. Oz to lead MFN talks

Endpoints 100 biotech survey: Welcome to the summer of biotech’s discontent

US warns drugmakers against misrepresenting cost of imported products

About 5% of CBER and CDER left after FDA staff cuts, analysis finds

Big leases, bigger regrets: Biotech slump turns swanky offices from asset into liability

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?